Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-11-22

Clinical Trial Update: Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating E2007 in levodopa-treated Parkinson's disease patients with motor fluctuations was terminated. Results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • E2007

Snippet

Sponsor: Eisai Limited | Conditions: Parkinson's Disease | Phase 3 | Status: TERMINATED | Results posted: 2012-11-22